论文部分内容阅读
目的 :研究恶性淋巴瘤患者中的乙型肝炎病毒感染状况。方法 :对连续收治的 114例恶性淋巴瘤患者进行乙肝三系及肝功能的检测 ,并随机抽取同期的 12 1例其他恶性肿瘤患者 (原发肝脏的恶性肿瘤除外 ) ,10 0例健康体检者作为对照进行比较。结果 :3组患者乙肝阳性率分别达 54.4 %、2 4 .8%和9% ;差异有显著性。结论 :淋巴瘤患者的HBV感染率显著高于普通人群和一般肿瘤患者人群 (肝癌除外 ) ,化疗容易引起有HBV感染患者的肝功能异常
Objective: To study the status of hepatitis B virus infection in patients with malignant lymphoma. METHODS: 114 patients with malignant lymphoma who were consecutively treated were tested for hepatitis B tri-line and liver function, and 121 patients with other malignant tumors (excluding primary malignant tumors) at the same period were randomly selected. 100 healthy volunteers were examined. Compare as a control. Results: The positive rates of hepatitis B in the three groups were 54.4%, 24.8%, and 9%, respectively; the difference was significant. Conclusion : The infection rate of HBV in patients with lymphoma is significantly higher than that in the general population and general cancer patients (except liver cancer). Chemotherapy easily leads to abnormal liver function in patients with HBV infection.